Giovanni Ferrara
Venture Partner,
pharmaceutical sciences
thesan pharma
Netherlands
Biography
Giovanni Ferrara joined Novartis Venture Funds in 2011. Prior, he spent three years as a consultant to leading west coast venture capital firms and portfolio companies. Most recently, he was consulting Chief Business Officer to Sorbent Therapeutics, where he raised $58M in two financings and led a refocusing of the company’s clinical activities and business development strategy. Previously, he was Managing Director and General Partner at Burrill& Company, and began his venture capital career at GeneChem Management, where he invested and also held operating positions in portfolio companies, including CEO of Targanta Therapeutics (then PhageTech, Inc.). He began his career in healthcare as a pharmacist at a cancer treatment center researching experimental therapies. He received his MBA and MSc at McGill University.
Research Interest
